333 related articles for article (PubMed ID: 33838838)
1. Emerging Systemic Therapeutic Biologics and Small Molecules for Atopic Dermatitis: How to Decide Which Treatment Is Right for Your Patients.
Ahn J; Grinich EE; Choi Y; Guttman-Yassky E; Simpson EL
J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1449-1460. PubMed ID: 33838838
[TBL] [Abstract][Full Text] [Related]
2. Relative efficacy of systemic treatments for atopic dermatitis.
Seger EW; Wechter T; Strowd L; Feldman SR
J Am Acad Dermatol; 2019 Feb; 80(2):411-416.e4. PubMed ID: 30296535
[TBL] [Abstract][Full Text] [Related]
3. Strategies for Successful Management of Severe Atopic Dermatitis.
Brar KK; Nicol NH; Boguniewicz M
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):1-16. PubMed ID: 30598172
[TBL] [Abstract][Full Text] [Related]
4. Current and emerging biologics for the treatment of pediatric atopic dermatitis.
Ghamrawi R; Bell KA; Balogh EA; Strowd LC; Feldman SR
Expert Opin Biol Ther; 2020 Dec; 20(12):1435-1445. PubMed ID: 33078990
[TBL] [Abstract][Full Text] [Related]
5. Dupilumab for the Treatment of Atopic Dermatitis.
Ferreira S; Torres T
Actas Dermosifiliogr (Engl Ed); 2018 Apr; 109(3):230-240. PubMed ID: 29422431
[TBL] [Abstract][Full Text] [Related]
6. Biological Therapies for Atopic Dermatitis: A Systematic Review.
Zhou S; Qi F; Gong Y; Zhang J; Zhu B
Dermatology; 2021; 237(4):542-552. PubMed ID: 33735876
[TBL] [Abstract][Full Text] [Related]
7. Current and emerging biologic and small molecule therapies for atopic dermatitis.
Li R; Hadi S; Guttman-Yassky E
Expert Opin Biol Ther; 2019 Apr; 19(4):367-380. PubMed ID: 30672355
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of biologics in atopic dermatitis.
Wu J; Guttman-Yassky E
Expert Opin Biol Ther; 2020 May; 20(5):525-538. PubMed ID: 32003247
[No Abstract] [Full Text] [Related]
9. [Status quo and prospects for systemic therapy of atopic dermatitis. Biologics ante portas].
Biedermann T; Werfel T
Hautarzt; 2015 Feb; 66(2):108-13. PubMed ID: 25645542
[TBL] [Abstract][Full Text] [Related]
10. Current and Future Monoclonal Antibodies in the Treatment of Atopic Dermatitis.
Chun PIF; Lehman H
Clin Rev Allergy Immunol; 2020 Oct; 59(2):208-219. PubMed ID: 32617839
[TBL] [Abstract][Full Text] [Related]
11. Review of Systemic Treatment Options for Adult Atopic Dermatitis.
Gooderham M; Lynde CW; Papp K; Bourcier M; Guenther L; Gulliver W; Hong CH; Poulin Y; Sussman G; Vender R
J Cutan Med Surg; 2017; 21(1):31-39. PubMed ID: 27635033
[TBL] [Abstract][Full Text] [Related]
12. Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches.
Moyle M; Cevikbas F; Harden JL; Guttman-Yassky E
Exp Dermatol; 2019 Jul; 28(7):756-768. PubMed ID: 30825336
[TBL] [Abstract][Full Text] [Related]
13. Dupilumab: A review of its use in the treatment of atopic dermatitis.
Gooderham MJ; Hong HC; Eshtiaghi P; Papp KA
J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S28-S36. PubMed ID: 29471919
[TBL] [Abstract][Full Text] [Related]
14. Modern therapies in atopic dermatitis: biologics and small molecule drugs.
Worm M; Francuzik W; Kraft M; Alexiou A
J Dtsch Dermatol Ges; 2020 Oct; 18(10):1085-1092. PubMed ID: 32666644
[TBL] [Abstract][Full Text] [Related]
15. Systemic Biologic Management of Atopic Dermatitis.
Dao DD; Flowers RH
Adv Exp Med Biol; 2024; 1447():139-149. PubMed ID: 38724791
[TBL] [Abstract][Full Text] [Related]
16. Dupilumab after the 2017 approval for the treatment of atopic dermatitis: what's new and what's next?
van der Schaft J; Thijs JL; de Bruin-Weller MS; Balak DMW
Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):341-349. PubMed ID: 31145194
[TBL] [Abstract][Full Text] [Related]
17. Biologics for Atopic Dermatitis.
Boguniewicz M
Immunol Allergy Clin North Am; 2020 Nov; 40(4):593-607. PubMed ID: 33012322
[TBL] [Abstract][Full Text] [Related]
18. [Not Available].
Lacour JP
Ann Dermatol Venereol; 2019 Dec; 146(12S3):12S76-12S84. PubMed ID: 31997736
[TBL] [Abstract][Full Text] [Related]
19. Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review.
Hendricks AJ; Yosipovitch G; Shi VY
J Dermatolog Treat; 2021 Feb; 32(1):19-28. PubMed ID: 31693426
[No Abstract] [Full Text] [Related]
20. EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers.
Bakker DS; Ariens LFM; Giovannone B; Hijnen D; Delemarre EM; Knol E; Nierkens S; de Bruin-Weller MS; Thijs JL; Drylewicz J
Allergy; 2020 Dec; 75(12):3287-3289. PubMed ID: 33305359
[No Abstract] [Full Text] [Related]
[Next] [New Search]